Vincent J. Angotti Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Vincent J. Angotti.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Vincent J. Angotti. Vincent J. Angotti is an Chief Executive Officer in ACELRX PHARMACEUTICALS INC ($ACRX).

Address: 351 GALVESTON DRIVE REDWOOD CITY 94063 CA

Companies in which Vincent J. Angotti is an Insider

ACELRX PHARMACEUTICALS INC

Trading Symbol: ACRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Vincent J. Angotti: Chief Executive Officer
Holdings: 636,980 shares
Current Value: $1,910,940
Latest Transaction: Mar 05 2021
$ACRX Market Capitalization: $131.47M
$ACRX Previous Close: $3.00

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Vincent J. Angotti

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 05 2021ACRXACELRX PHARMACEUTI ...Angotti Vincent J.Chief Executive Off ...Option ExerciseA1.881,000,0001,880,0001,000,000
Mar 05 2021ACRXACELRX PHARMACEUTI ...Angotti Vincent J.Chief Executive Off ...GrantA0.00200,0000636,980437 K to 637 K (+45.77 %)
Feb 12 2021ACRXACELRX PHARMACEUTI ...Angotti Vincent J.Chief Executive Off ...Payment of ExerciseF2.6323,05260,627427,887450.9 K to 427.9 K (-5.11 %)
Feb 09 2021ACRXACELRX PHARMACEUTI ...Angotti Vincent J.Chief Executive Off ...Payment of ExerciseF2.5925,05964,903450,939476 K to 450.9 K (-5.26 %)
Jun 15 2020ACRXACELRX PHARMACEUTI ...Angotti Vincent J.Chief Executive Off ...BuyP1.337,54710,035468,757461.2 K to 468.8 K (+1.64 %)
Feb 13 2020ACRXACELRX PHARMACEUTI ...Angotti Vincent J.Chief Executive Off ...Payment of ExerciseF1.7123,05239,419452,892475.9 K to 452.9 K (-4.84 %)
Feb 07 2020ACRXACELRX PHARMACEUTI ...Angotti Vincent J.Chief Executive Off ...Option ExerciseA1.72400,000688,000400,000

View all Vincent J. Angotti insider transactions.